<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397496079</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164521.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199506  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1016/S1010-7940(05)80191-5</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1016/S1010-7940(05)80191-5</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Prophylaxis in cardiac surgery. A controlled randomized comparison between cefazolin and cefuroxime</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">In a prospective randomized two center trial, short-term prophylaxiswith cefuroxime (CFX) in 189 patients was compared with cefazolin (CFZ) in196 patients submitted to elective cardiac surgery. A total of 3 g wasadministered over 24 h in both groups. One major adverse reaction with CFXwas noted. Patients were prospectively screened by infectious diseasenurses for surgical wound and secondary infections. Sternal woundinfections occurred in eight patients treated with CFX and all were minor.One patient from this group eventually died of infectious causes. In theCFZ-treated patients two major and six minor wound infections occurredrequiring extensive debridement in two. Secondary infections occurred lessfrequently in the CFX group (13.2 per 100) than in the CFZ group (16.8 per100) with two infection-related deaths in the CFX and one in the CFZ group.The most commonly identified organisms were Staphylococcus aureus and avariety of gram-negative organisms. No major differences were observedbetween the CFX and CFZ groups. Short-term administration of 3 g CFZ or CFXin this study could not demonstrate the advantage of one of the antibioticsused over the other in terms of clinical outcome, incidence or site ofinfection or organisms identified. The 24 h administration of 3 g CFZ orCFX provided suboptimal prophylaxis for wound infection or secondaryinfections in patients undergoing elective open heart surgery.</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V.</subfield>
   <subfield code="g">9/6(1995-06), 325-329</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:6&lt;325</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1016/S1010-7940(05)80191-5</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">abstract</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1016/S1010-7940(05)80191-5</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V</subfield>
   <subfield code="g">9/6(1995-06), 325-329</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:6&lt;325</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
